IO Biotech (IOBT) is scheduled to report topline results of its pivotal Phase 3 trial of its investigational off-the-shelf therapeutic cancer vaccine, Cylembio, in combination with Merck's Keytruda as a first-line treatment for unresectable or metastatic (advanced) melanoma today. Shares are up over 35%.
The following is the list of biotech stocks making big moves in premarket trading today.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com